Inmed Pharmaceuticals Stock Alpha and Beta Analysis
| INM Stock | USD 4.50 0.16 3.43% |
This module allows you to check different measures of market premium (i.e., alpha and beta) for all equities such as InMed Pharmaceuticals. It also helps investors analyze the systematic and unsystematic risks associated with investing in InMed Pharmaceuticals over a specified time horizon. Remember, high InMed Pharmaceuticals' alpha is almost always a sign of good performance; however, a high beta will depend on investors' risk tolerance level and may signal increased volatility and potential future overvaluation. Key technical indicators related to InMed Pharmaceuticals' market risk premium analysis include:
Beta 0.17 | Alpha (0.65) | Risk 6.96 | Sharpe Ratio (0.09) | Expected Return (0.62) |
Enterprise Value |
|
Alpha is a measure of relative performance on a risk-adjusted basis, while beta measures volatility against the benchmark. The goal is to know if an investor is being compensated for the volatility risk taken. The return on investment might be better than its reference but still not compensate for the assumption of the risk.
InMed |
InMed Pharmaceuticals Market Premiums
Investors always prefer to have the highest possible return on investment, coupled with the lowest possible volatility. InMed Pharmaceuticals market risk premium is the additional return an investor will receive from holding InMed Pharmaceuticals long position in a well-diversified portfolio. The market premium is part of the Capital Asset Pricing Model (CAPM), which most analysts and investors use to calculate the acceptable rate of return on investment in InMed Pharmaceuticals. At the center of the CAPM is the concept of risk and reward, which is usually communicated by investors using alpha and beta measures. Alpha and beta are two of the key measurements used to evaluate InMed Pharmaceuticals' performance over market.| α | -0.65 | β | 0.17 |
InMed Pharmaceuticals expected buy-and-hold returns
Although buy-and-hold investment strategy may not appeal to all investors, it may be used as a good measure of InMed Pharmaceuticals' Buy-and-hold return. Our buy-and-hold chart shows how InMed Pharmaceuticals performed over your current time horizon against a typical interest-earning bank account and a selected benchmark.InMed Pharmaceuticals Market Price Analysis
Market price analysis indicators help investors to evaluate how InMed Pharmaceuticals stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading InMed Pharmaceuticals shares will generate the highest return on investment. By understating and applying InMed Pharmaceuticals stock market price indicators, traders can identify InMed Pharmaceuticals position entry and exit signals to maximize returns.
InMed Pharmaceuticals Return and Market Media
The median price of InMed Pharmaceuticals for the period between Tue, Aug 27, 2024 and Mon, Nov 25, 2024 is 5.04 with a coefficient of variation of 20.19. The daily time series for the period is distributed with a sample standard deviation of 1.06, arithmetic mean of 5.28, and mean deviation of 0.82. The Stock received substential amount of media coverage during this period. Price Growth (%) |
| Timeline |
1 | InMed receives NASDAQ delisting notice | 09/20/2024 |
2 | INM Stock Earnings InMed Pharmaceuticals Reported Results for Q3 2024 - MSN | 09/23/2024 |
3 | InMed Pharmaceuticals Reports Full Year Fiscal 2024 Financial Results and Provides Business Update | 09/30/2024 |
4 | Acquisition by Adams Eric A of 11400 shares of InMed Pharmaceuticals at 1.753 subject to Rule 16b-3 | 10/14/2024 |
5 | InMed Pharmaceuticals Files Additional Patent Application for INM-901 in the Treatment of Neurodegenerative Conditions Including Alzheimers Disease | 10/28/2024 |
6 | InMed announces share consolidation to satisfy Nasdaq listing rules | 11/08/2024 |
7 | ARMISTICE CAPITAL, LLC Acquires New Holdings in InMed Pharmaceuticals Inc | 11/15/2024 |
8 | InMed Pharmaceuticals Price-to-Free-Cash-Flow NA - GuruFocus.com | 11/21/2024 |
About InMed Pharmaceuticals Beta and Alpha
For many years both, Alpha and Beta indicators are used by professional money managers as critical performance measurement tools across virtually all financial instruments including InMed or other stocks. Alpha measures the amount that position in InMed Pharmaceuticals has returned in comparison to a selected market index or another relevant benchmark. In other words, Alpha is the excess return on an investment relative to the performance of your selected benchmark. Beta, on the other hand, measures the relative risk of your investment.
| 2022 | 2023 | 2024 (projected) | Graham Number | 18.99 | 5.26 | 208.7 | Receivables Turnover | 15.88 | 13.03 | 10.07 |
InMed Pharmaceuticals Upcoming Company Events
As portrayed in its financial statements, the presentation of InMed Pharmaceuticals' financial position is often influenced by management's estimates, judgments, and sometimes even manipulations. In the best case, InMed Pharmaceuticals' leadership is honest, while the outside auditors are strict and uncompromising. Whatever the case, investors should always follow all of InMed Pharmaceuticals' public filing events to personally review all filings and be reasonable and skeptical to interpret all of the financial statements of InMed Pharmaceuticals. Please utilize our Beneish M Score to check the likelihood of InMed Pharmaceuticals' management manipulating its earnings.
| 16th of February 2024 Upcoming Quarterly Report | View | |
| 31st of December 2023 Next Fiscal Quarter End | View |
Build Portfolio with InMed Pharmaceuticals
Your optimized portfolios are the building block of your wealth. We provide an intuitive interface to determine which securities in a portfolio should be removed or rebalanced to achieve better diversification, find the right mix of securities that minimizes portfolio risk for a given return, or maximize portfolio expected return for a given risk level.Build Diversified Portfolios
Align your risk with return expectations
Check out InMed Pharmaceuticals Backtesting, InMed Pharmaceuticals Valuation, InMed Pharmaceuticals Correlation, InMed Pharmaceuticals Hype Analysis, InMed Pharmaceuticals Volatility, InMed Pharmaceuticals History and analyze InMed Pharmaceuticals Performance. To learn how to invest in InMed Stock, please use our How to Invest in InMed Pharmaceuticals guide.You can also try the Portfolio Center module to all portfolio management and optimization tools to improve performance of your portfolios.
InMed Pharmaceuticals technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.